These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 17160723)

  • 21. Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol.
    Gómez-Marcos MA; Recio-Rodríguez JI; Rodríguez-Sánchez E; Castaño-Sánchez Y; de Cabo-Laso A; Sánchez-Salgado B; Rodríguez-Martín C; Castaño-Sánchez C; Gómez-Sánchez L; García-Ortiz L
    BMC Public Health; 2010 Mar; 10():143. PubMed ID: 20298558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vascular complications of diabetes: is there a glycemic threshold?].
    Isnard F; Eschwège E
    Rev Prat; 2001 Oct; 51(16):1759-64. PubMed ID: 11795118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes.
    Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K
    Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms linking diabetes to the accelerated development of atherosclerosis.
    Zeadin MG; Petlura CI; Werstuck GH
    Can J Diabetes; 2013 Oct; 37(5):345-50. PubMed ID: 24500563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic variability in the development of cardiovascular complications in diabetes.
    Nusca A; Tuccinardi D; Albano M; Cavallaro C; Ricottini E; Manfrini S; Pozzilli P; Di Sciascio G
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3047. PubMed ID: 30028067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
    Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
    Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes and cardiovascular disease. Introduction.
    Chait A
    Atheroscler Suppl; 2006 Aug; 7(4):1-4. PubMed ID: 16822721
    [No Abstract]   [Full Text] [Related]  

  • 28. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context.
    Gore MO; McGuire DK
    Diab Vasc Dis Res; 2009 Jan; 6(1):53-5. PubMed ID: 19156632
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: action LADA 5.
    Pham MN; Hawa MI; Roden M; Schernthaner G; Pozzilli P; Buzzetti R; Scherbaum WA; Seissler J; Hunter S; Leslie RD; Kolb H; Schloot NC;
    Diabet Med; 2012 Apr; 29(4):470-8. PubMed ID: 22150724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes?
    Maahs DM
    Diabetes Technol Ther; 2012 Jun; 14(6):449-52. PubMed ID: 22472062
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 33. Vascular compliance in diabetes.
    Winer N; Sowers JR
    Curr Diab Rep; 2003 Jun; 3(3):230-4. PubMed ID: 12762971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes mellitus and dementia.
    Ninomiya T
    Curr Diab Rep; 2014; 14(5):487. PubMed ID: 24623199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history of macrovascular disease in type 2 diabetes. Role of insulin resistance.
    Stern M
    Diabetes Care; 1999 Apr; 22 Suppl 3():C2-5. PubMed ID: 10189555
    [No Abstract]   [Full Text] [Related]  

  • 36. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 37. Aspects of Hyperglycemia Contribution to Arterial Stiffness and Cardiovascular Complications in Patients With Type 1 Diabetes.
    Gordin D; Groop PH
    J Diabetes Sci Technol; 2016 Sep; 10(5):1059-64. PubMed ID: 26956240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrovascular Complications in Patients with Diabetes and Prediabetes.
    Huang D; Refaat M; Mohammedi K; Jayyousi A; Al Suwaidi J; Abi Khalil C
    Biomed Res Int; 2017; 2017():7839101. PubMed ID: 29238721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modifications of structural and functional properties of large arteries in diabetes mellitus].
    Bortolotto LA
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):176-84. PubMed ID: 17505624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum uromodulin inversely associates with aortic stiffness in youth with type 1 diabetes: A brief report from EMERALD study.
    Wiromrat P; Bjornstad P; Roncal C; Cree-Green M; Baumgartner A; Coe G; Reyes YG; Schäfer M; Truong U; Pyle L; Johnson RJ; Nadeau KJ
    J Diabetes Complications; 2019 Jun; 33(6):434-436. PubMed ID: 31003921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.